Clinical Trials on Autoimmune Diseases in United Kingdom

Total 146467 results

Takeda

Completed

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants

Autoimmune Disease

United Kingdom
CSL Behring

Terminated

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects

Immune Complex-mediated Autoimmune Diseases

United Kingdom
Sanofi

Completed

Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects

Multiple Sclerosis

United Kingdom
GlaxoSmithKline

Completed

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants

Multiple Sclerosis

United Kingdom
Queen Margaret University

Recruiting

The Effects of FES in a Variety of Walking Conditions in People With MS

Multiple Sclerosis

United Kingdom
University of Edinburgh

Completed

Neuroretinal Biomarkers in Neurodegenerative Diseases

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Imperial College London

Completed

Stem Cells in Rapidly Evolving Active Multiple Sclerosis (STREAMS)

Multiple Sclerosis

United Kingdom
Queen Mary University of London
Novartis Pharmaceuticals; University College, London; Barts & The London NHS... and other collaborators

Completed

Protective Role of Oxcarbazepine in Multiple Sclerosis (PROXIMUS)

Multiple Sclerosis

United Kingdom
University of Nottingham
University of Lincoln; MS Society

Recruiting

Who Benefits Most From Cognitive Rehabilitation for Multiple Sclerosis?

Multiple Sclerosis

United Kingdom
University of Lincoln
University of Nottingham; National University of Ireland, Maynooth; University... and other collaborators

Recruiting

Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility Trial (SMART_MS)

Multiple Sclerosis

United Kingdom
Nottingham University Hospitals NHS Trust

Completed

DECISIve - DiagnosE Using the Central veIn SIgn v1.0 (DECISiVE)

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

Multiple Sclerosis

United Kingdom
Queen Mary University of London
Roche Pharma AG; Barts & The London NHS Trust

Completed

Under and Over Rehabilitation Study

Multiple Sclerosis

United Kingdom
Cardiff University

Completed

Life-Style Exercise and Activity Package for People Living With Progressive MS (LEAP-MS)

Multiple Sclerosis

United Kingdom
GlaxoSmithKline

Terminated

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
King's College London
National Multiple Sclerosis Society

Completed

Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)

Multiple Sclerosis

United Kingdom
University of Nottingham

Completed

Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2 (PrEliMS2)

Multiple Sclerosis

United Kingdom
Pipeline Therapeutics, Inc.

Completed

PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers

Multiple Sclerosis

United Kingdom
The Leeds Teaching Hospitals NHS Trust
University of Leeds

Completed

Kinematic Assessment In Multiple Sclerosis (KAIMS)

Multiple Sclerosis

United Kingdom
University of Nottingham
Swansea University; Multiple Sclerosis Society UK

Completed

The PrEliMS Feasibility Trial (PrEliMS)

Multiple Sclerosis

United Kingdom
University College, London
University College London Hospitals

Unknown

Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis (RELOAD-MS)

Multiple Sclerosis

United Kingdom
NHS Greater Glasgow and Clyde
University of Glasgow

Completed

Mindfulness-based Stress Reduction in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Queen Mary University of London

Recruiting

Famciclovir in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis | Spasticity

United Kingdom
GlaxoSmithKline

Terminated

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
Edinburgh Napier University
Scottish Hospital Endowments Research Trust; Pacla Medical Ltd

Completed

MS Spinal Mobilisation Study

Multiple Sclerosis

United Kingdom
University of Nottingham

Unknown

Baseline Cortical Haemodynamics in MS (CortHaem)

Multiple Sclerosis

United Kingdom
University of Nottingham

Unknown

Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis (STAR-MS)

Multiple Sclerosis

United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis (AIMS)

Multiple Sclerosis

United Kingdom
University of Nottingham

Withdrawn

Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. (WIRMS-1)

Multiple Sclerosis

United Kingdom
NHS Greater Glasgow and Clyde
University of Glasgow

Completed

Effect of Active-Passive Trainer Cycling on Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Imperial College London

Recruiting

Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target (TSPO)

Multiple Sclerosis

United Kingdom
Glasgow Caledonian University
NHS Lanarkshire; MS Society, UK

Completed

Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Cambridge University Hospitals NHS Foundation Trust

Terminated

Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis (CAM-THY)

Multiple Sclerosis

United Kingdom
North Bristol NHS Trust
Sir Halley Stewart Trust

Completed

Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis (SIAMMS-II)

Multiple Sclerosis

United Kingdom
University of the West of Scotland
National Heatlh Service Ayrshire and Arran

Unknown

Exercise Intensity and Immune Function in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
East Kent Hospitals University NHS Foundation Trust

Completed

Robotics for Mobility Rehabilitation in MS (RAPPERIII)

Multiple Sclerosis | MS

United Kingdom
Queen Mary University of London
Biogen; Barts & The London NHS Trust; Moorfields Eye Hospital NHS Foundation... and other collaborators

Recruiting

Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS) (AttackMS)

Multiple Sclerosis | Clinically Isolated Syndrome of Demyelination

United Kingdom
Queen Mary University of London

Terminated

Neurofilaments for NEDA Assessing in MS

Multiple Sclerosis

United Kingdom
AbbVie

Terminated

[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Trio Medicines Ltd.
Biogen

Completed

Avonex®: Safety, Blood Levels and Effects (C-851)

Multiple Sclerosis (MS)

United Kingdom
University of Edinburgh

Completed

Self Help for Fatigue in Multiple Sclerosis

Multiple Sclerosis | Fatigue

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Recruiting

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Multiple Sclerosis

United Kingdom
NHS Greater Glasgow and Clyde
Biogen

Enrolling by invitation

Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimE (MODERATE)

Relapsing Remitting Multiple Sclerosis

United Kingdom
North Bristol NHS Trust
University of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaborators

Unknown

Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) (ACTiMuS)

Progressive Multiple Sclerosis

United Kingdom
University of Glasgow
NHS Ayrshire and Arran; AKM

Completed

Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.

Progressive Multiple Sclerosis

United Kingdom
The Leeds Teaching Hospitals NHS Trust

Unknown

Preventing Job Loss Using Acceptance and Commitment Therapy in Vocational Rehabilitation (MS-Proactive)

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

A Study of the Long-term Safety of Sativex Use

Pain | Multiple Sclerosis | Spasticity

United Kingdom

Clinical Trials on Autoimmune Diseases in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations